GRAIL, Inc.

GRAL · Nasdaq · SIC 8071: Services-Medical Laboratories
35
SEC Filings

Business Summary

PART I Our Company Our mission is to detect cancer early, when it can be cured. We are an innovative commercial-stage healthcare company focused on shifting the paradigm in early cancer detection at population scale. We believe screening individuals for many types of cancer with a single test represents a significant opportunity to reduce the global burden of cancer. Our multi-cancer early detection test (Galleri) can screen for many types of cancer, accurately predicting the specific organ or t...

Next Earnings

Q2 FY2026 — expected 2026-09-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionGRALdiscussed_in_filing Cybersecurity
topic_mentionGRALdiscussed_in_filing Trusted Computing
topic_mentionGRALdiscussed_in_filing Blockchain & Crypto
topic_mentionGRALdiscussed_in_filing Regulation
topic_mentionGRALdiscussed_in_filing Healthcare & Bio
topic_mentionGRALdiscussed_in_filing Platform & Ecosystem
topic_mentionGRALdiscussed_in_filing Sovereign & Government
topic_mentionGRALdiscussed_in_filing Cybersecurity
topic_mentionGRALdiscussed_in_filing Trusted Computing
topic_mentionGRALdiscussed_in_filing Blockchain & Crypto
topic_mentionGRALdiscussed_in_filing Regulation
topic_mentionGRALdiscussed_in_filing Healthcare & Bio
topic_mentionGRALdiscussed_in_filing Platform & Ecosystem
topic_mentionGRALdiscussed_in_filing Sovereign & Government
topic_mentionGRALdiscussed_in_filing Cybersecurity
topic_mentionGRALdiscussed_in_filing Trusted Computing
topic_mentionGRALdiscussed_in_filing Blockchain & Crypto
topic_mentionGRALdiscussed_in_filing Regulation
topic_mentionGRALdiscussed_in_filing Healthcare & Bio
topic_mentionGRALdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001628280-26-017319EDGAR130K words
2025-03-052024-12-310001699031-25-000041EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001699031-25-000193EDGAR39K words
2025-08-132025-06-300001699031-25-000166EDGAR
2025-05-142025-03-310001699031-25-000114EDGAR
2024-11-132024-09-300001628280-24-047606EDGAR
2024-08-132024-06-300001628280-24-036965EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-190001699031-26-000009EDGAR4K words
2026-01-120001628280-26-001786EDGAR
2025-11-140001628280-25-052184EDGAR
2025-11-120001699031-25-000189EDGAR
2025-10-200001628280-25-045532EDGAR
2025-10-160001628280-25-045239EDGAR
2025-09-180001699031-25-000180EDGAR
2025-08-120001699031-25-000162EDGAR
2025-05-300001699031-25-000122EDGAR
2025-05-160001699031-25-000120EDGAR

35 total filings indexed. 18 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

AMS — AMERICAN SHARED HOSPITAL SERVICES ACON — Aclarion, Inc. ADVB — Advanced Biomed Inc. BDSX — BIODESIX INC BLLN — BillionToOne, Inc. BGLC — BioNexus Gene Lab Corp CSTL — CASTLE BIOSCIENCES INC CFOR — CapForce Inc.

Company Identity

CIK0001699031
TickerGRAL
ExchangeNasdaq
SIC8071: Services-Medical Laboratories
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: c35dd119e0a10390664c7b6517a230bcac60fe9343e63770ca5acf4433730d5a
parent: 6887747fcc1515ba8ae6049b3b05dbec65f62125f4c669063c202872a309201c
content hash: 0b122cfb4ab83acf85dc8c2c8a314cfd285c38b86428b0c764496c98389d64f7
signed: 2026-04-13T04:45:21.782Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf